Olympia Pharmaceuticals Launches Rebranded Website, Ushering in a New Era of Seamless Navigation and Advanced Features

The updated site optimizes user interaction and strengthens Olympia's commitment to modern pharmaceutical solutions

ORLANDO, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, the nation’s leading 503A and 503B compounding pharmacy, today announced the launch of its rebranded website, crafted to offer a user-friendly platform that reflects the company’s mission of delivering high-quality medications that fill crucial care gaps, support providers, and improve patient health outcomes.

The site features a refreshed look that streamlines navigation and enhances usability for healthcare professionals, industry collaborators, and patients alike. The website’s Medication Directory has been overhauled to increase ease of use for patients and providers searching for products. Contact submission forms have also been revamped to help better connect prospective customers to Olympia’s team. Additionally, the website incorporates sleek branding elements that embrace a refined color palette and aesthetic, tying it stylistically to Olympia’s sister brand, Wesley Pharmaceuticals.

“The rebranding of Olympia’s website is a clear reflection of our long-term strategy to invest in digital progress and advance service delivery,” said Mark Mikhael, CEO of Olympia Pharmaceuticals. “It also underscores our commitment to ensuring that medical providers, industry partners, and patients benefit from improved accessibility and usability in a rapidly evolving healthcare landscape.”

The launch of the new website is part of Olympia’s broader initiative to modernize its digital infrastructure and deepen its connections within the healthcare industry. This is a key step in the company’s ongoing effort to lead the compounding pharmacy sector by setting the highest standards for quality, efficiency, and customer engagement.

“To support our continued growth, Olympia Pharmaceuticals is dedicated to expanding its reach and advancing the patient and provider experience,” added Mikhael. “This website launch is just one of many initiatives that will allow us to better serve our clients and partners as we move forward.”

To view the new website and learn more about the pharmaceutical solutions available to you, please visit https://www.olympiapharmacy.com/.

About Olympia Pharmaceuticals
Olympia Pharmaceuticals is a state-of-the-art, FDA-registered 503B pharmaceutical outsourcing facility and 503A pharmacy supporting both patient-specific and office-use needs across the U.S. Co-founded by Stan and Naomi Loomis, the team is made up of pharmacy technicians, pharmacists, quality personnel, and engineers, creating an educated and experienced staff knowledgeable in all facets of pharmacy production. As an FDA-registered outsourcing facility, Olympia offers compounded medications to 49 states for both office use and patient prescriptions. Olympia specializes in weight loss, dermatology, IV nutritional therapy, erectile dysfunction, and more.

Media Contact
Daniele Spring
Uproar by Moburst for Olympia and Wesley Pharmaceuticals
Daniele.Spring@Moburst.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.